Voyager Therapeutics, Inc. Retained Earnings
Voyager Therapeutics, Inc. (VYGR) had Retained Earnings of -$498.31 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$498.31M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$473.84M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$445.90M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$418.48M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$498.31M 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$473.84M 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$445.90M 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$418.48M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$390.59M 10-Q · filed 2025-08-06 |
| 2025-03-31 | -$357.20M 10-Q · filed 2025-05-06 |
| 2024-12-31 | -$326.18M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$291.70M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$282.65M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$272.51M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$261.18M 10-K · filed 2025-03-11 |
| 2023-09-30 | -$317.58M 10-Q · filed 2023-11-06 |
| 2023-06-30 | -$291.68M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$269.47M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$393.51M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$369.89M 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$387.51M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$368.42M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$347.10M 10-K · filed 2023-03-07 |
| 2021-09-30 | -$352.81M 10-Q · filed 2021-11-02 |
| 2021-06-30 | -$327.68M 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$297.56M 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$275.91M 10-K · filed 2022-03-08 |
| 2020-09-30 | -$259.98M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$345.59M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$336.91M 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$312.65M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$300.07M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$285.07M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$296.22M 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$269.05M 10-K · filed 2020-03-03 |
| 2018-09-30 | -$246.52M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$226.23M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$200.69M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$160.71M 10-K · filed 2019-02-26 |
| 2017-09-30 | -$148.88M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$125.54M 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$106.66M 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$90.02M 10-K · filed 2018-03-14 |
| 2016-09-30 | -$75.34M 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$66.34M 10-Q · filed 2016-08-11 |
| 2016-03-31 | -$57.01M 10-Q · filed 2016-05-12 |
| 2015-12-31 | -$49.82M 10-K · filed 2017-03-15 |
| 2015-09-30 | -$47.18M 10-Q · filed 2015-12-17 |
| 2014-12-31 | -$20.83M 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |